D
Denis Y. Logunov
Researcher at Russian Academy
Publications - 82
Citations - 3440
Denis Y. Logunov is an academic researcher from Russian Academy. The author has contributed to research in topics: Vaccination & Medicine. The author has an hindex of 19, co-authored 62 publications receiving 1936 citations. Previous affiliations of Denis Y. Logunov include Russian Academy of Sciences.
Papers
More filters
Journal ArticleDOI
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Denis Y. Logunov,Inna V. Dolzhikova,Dmitry V. Shcheblyakov,A. I. Tukhvatulin,Olga V. Zubkova,Alina S. Dzharullaeva,Anna V. Kovyrshina,Nadezhda L. Lubenets,Daria M. Grousova,Alina S. Erokhova,Andrei G. Botikov,Fatima M. Izhaeva,Olga Popova,Tatiana A Ozharovskaya,Ilias B Esmagambetov,Irina A Favorskaya,Denis I. Zrelkin,Daria V Voronina,Dmitry N. Shcherbinin,Alexander S. Semikhin,Yana V. Simakova,Elizaveta A. Tokarskaya,Daria A. Egorova,M M Shmarov,Natalia A. Nikitenko,Vladimir A. Gushchin,Elena A Smolyarchuk,Sergey Zyryanov,Sergei V. Borisevich,Boris S. Naroditsky,Alexander L. Gintsburg +30 more
TL;DR: Gam-COVID-Vac (Sputnik V) showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials as discussed by the authors.
Journal ArticleDOI
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Denis Y. Logunov,Inna V. Dolzhikova,Olga V. Zubkova,Amir I Tukhvatullin,Dmitry V. Shcheblyakov,Alina S. Dzharullaeva,Daria M. Grousova,Alina S. Erokhova,Anna V. Kovyrshina,Andrei G. Botikov,Fatima M. Izhaeva,Olga Popova,Tatiana A Ozharovskaya,Ilias B Esmagambetov,Irina A Favorskaya,Denis I. Zrelkin,Daria V Voronina,Dmitry N. Shcherbinin,Alexander S. Semikhin,Yana V. Simakova,Elizaveta A. Tokarskaya,Nadezhda L. Lubenets,Daria A. Egorova,M M Shmarov,Natalia A. Nikitenko,Morozova Lf,Elena A Smolyarchuk,Evgeny V Kryukov,Vladimir F Babira,Sergei V. Borisevich,Boris S. Naroditsky,Alexander L. Gintsburg +31 more
TL;DR: The heterologous rAd26 and rAd5 vector-based COVID-19 vaccine has a good safety profile and induced strong humoral and cellular immune responses in participants and was safe and well tolerated.
Journal ArticleDOI
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist
Lyudmila G. Burdelya,Craig M. Brackett,Bojidar Kojouharov,Ilya Gitlin,Katerina I. Leonova,Anatoli S. Gleiberman,Semra Aygun-Sunar,Jean Veith,Christopher Johnson,Gary Haderski,Patricia Stanhope-Baker,Shyam Allamaneni,Joseph J. Skitzki,Ming Zeng,Elena Martsen,Alexander Medvedev,Dmitry Scheblyakov,Nataliya M. Artemicheva,Denis Y. Logunov,Alexander L. Gintsburg,Boris S. Naroditsky,Sergei S. Makarov,Andrei V. Gudkov +22 more
TL;DR: The liver is defined as the key mediator ofTLR5-dependent effects in vivo and clinical applications for TLR5 agonists as hepatoprotective and antimetastatic agents are suggested.
Journal ArticleDOI
Association of Mycoplasma hominis infection with prostate cancer.
Yulia A. Barykova,Denis Y. Logunov,Maxim M. Shmarov,Andrei Zinov'yevich Vinarov,D.N. Fiev,Natalia A. Vinarova,I. V. Rakovskaya,Patricia Stanhope Baker,Inna Shyshynova,Andrew James Stephenson,Eric A. Klein,Boris S. Naroditsky,Alexander L. Gintsburg,Andrei V. Gudkov +13 more
TL;DR: Screening prostate biopsies from two groups of Russian men undergoing PCa diagnosis suggest that M. hominis infection may be involved in PCa development and may, therefore, be a potential PCa marker and/or target for improved prevention and treatment of this disease.
Journal ArticleDOI
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants.
Vladimir A. Gushchin,Inna V. Dolzhikova,Shchetinin Am,Alina S. Odintsova,Andrei E. Siniavin,Maria A. Nikiforova,Andrei A. Pochtovyi,Elena V. Shidlovskaya,Nadezhda A. Kuznetsova,Olga A. Burgasova,Liudmila V. Kolobukhina,Anna A. Iliukhina,Anna V. Kovyrshina,Botikov Ag,Aleksandra V. Kuzina,Daria M. Grousova,A. I. Tukhvatulin,Dmitry V. Shcheblyakov,Olga V. Zubkova,Oksana V. Karpova,Olga L. Voronina,Natalia N. Ryzhova,Ekaterina I. Aksenova,M.S. Kunda,Dmitry Lioznov,Daria Danilenko,Andrey Komissarov,Artem P. Tkachuck,Denis Y. Logunov,Alexander L. Gintsburg +29 more
TL;DR: In this paper, the authors evaluated the effect of the Sputnik V vaccine against the B.1.617 genotype in terms of virus neutralization and epidemiological efficacy.